Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle

Journal of Clinical Investigation

Volumn 114, Issue 11, 2004, Pages 1577-1585

  Lapidos, Karen A ^a   Chen, Yiyin E ^a   Earley, Judy U ^a   Heydemann, Ahlke ^a   Huber, Jill M ^a   Chien, Marcia ^b   Ma, Averil ^b   McNally, Elizabeth M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA SARCOGLYCAN; SARCOGLYCAN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED SIDE POPULATION STEM CELL; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL MATURATION; CELL NUCLEUS; CONTROLLED STUDY; DELTA SARCOGLYCAN GENE; GENE; GENE EXPRESSION; GRAFT SURVIVAL; HEART INFARCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC SYSTEM; MOUSE; MOUSE STRAIN; MUSCLE ATROPHY; MUSCLE FIBRIL; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; SARCOGLYCAN GENE; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; CELL SEPARATION; CYTOLOGY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HEART; HEART MUSCLE; HEMATOPOIETIC STEM CELL; HISTOLOGY; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; PLURIPOTENT STEM CELL; RADIATION EXPOSURE; Y CHROMOSOME;

ANIMALS; BIOLOGICAL MARKERS; CELL NUCLEUS; CELL SEPARATION; FEMALE; HEART; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MYOCARDIUM; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; SARCOGLYCANS; Y CHROMOSOME;

EID: 13944254851     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200423071     Document Type: Article

References (54)

1. Frisen, J. 2002. Stem cell plasticity? Neuron. 35:415-418.
2. Morrison, S.J. 2001. Stem cell potential: can anything make anything? Curr. Biol. 11:R7-R9.
3. Corti, S., et al. 2002. A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse. Exp. Cell Res. 277:74-85.
4. LaBarge, M.A., and Blau, H.M. 2002. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell. 111:589-601.
5. Camargo, F.D., Green, R., Capetenald, Y., Jackson, K.A., and Goodell, M.A. 2003. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat. Med. 9:1520-1527.
6. Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., and Mulligan, R.C. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183:1797-1806.
7. Gussoni, E., et al. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 401:390-394.
8. Jackson, K.A., et al. 2001. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107:1395-1402.
9. Montanaro, F., Liadaki, K., Volinski, J., Flint, A., and Kunkel, L.M. 2003. Skeletal muscle engraftment potential of adult mouse skin side population cells. Proc. Natl. Acad. Sci. U. S. A. 100:9336-9341.
10. Welm, B.E., et al. 2002. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 245:42-56.
11. Hierlihy, A.M., Seale, P., Lobe, C.G., Rudnicki, M.A., and Megeney, L.A. 2002. The post-natal heart contains a myocardial stem cell population. FEBS Lett. 530:239-243.
12. Orlic, D., et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature. 410:701-705.
13. Murry, C.E., et al. 2004. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 428:664-668.
14. Bittner, R.E., et al. 1999. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat. Embryol. 199:391-396.
15. Hack, A.A., et al. 2000. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J. Cell Sci. 113:2535-2544.
16. Lynch, G.S., Rafael, J.A., Chamberlain, J.S., and Faulkner, J.A. 2000. Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice. Am. J. Physiol. Cell Physiol. 279:C1290-C1294.
17. Coral-Vazquez, R., et al. 1999. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 98:465-474.
18. Factor, S.M., Minase, T., Cho, S., Dominitz, R., and Sonnenblick, E.H. 1982. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation. 66:342-354.
19. Corbel, S.Y., et al. 2003. Contribution of hematopoetic poietic stem cells to skeletal muscle. Nat. Med. 9:1528-1532.
20. Torrente, Y., et al. 2001. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J. Cell Biol. 152:335-348.
21. Irintchev, A., Langer, M., Zweyer, M., Theisen, R., and Wernig, A. 1997. Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts. J. Physiol. 500:775-785.
22. Cordier, L., et al. 2001. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Hum. Gene Ther. 12:205-215.
23. Greelish, J.P., et al. 1999. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat. Med. 5:439-443.
24. Li, J., et al. 1999. rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy. Gene Ther. 6:74-82.
25. Wheeler, M.T., et al. 2004. Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy. J. Clin. Invest. 113:668-675. doi:10.1172/JCI200420410.
26. Beauchamp, J.R., Morgan, J.E., Pagel, C.N., and Partridge, T.A. 1999. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144:1113-1122.
27. Morgan, J.E., Pagel, C.N., Sherratt, T., and Partridge, T.A. 1993. Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice. J. Neurol. Sci. 115:191-200.
28. Porter, J.D., et al. 2002. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystroph in-deficient mdx mice. Hum. Mol. Genet. 11:263-272.
29. Orlic, D., et al. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 98:10344-10349.
30. Balsam, L.B., et al. 2004. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 428:668-673.
31. Bittmann, I., Hentrich, M., Bise, K., Kolb, H.J., and Lohrs, U. 2003. Endothelial cells but not epithelial cells or cardiomyocytes are partially replaced by donor cells after allogeneic bone marrow and stem cell transplantation. J. Hematother. Stem Cell Res. 12:359-366.
32. Deb, A., et al. 2003. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation. 107:1247-1249.
33. Glaser, R., Lu, M.M., Narula, N., and Epstein, J.A. 2002. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation. 106:17-19.
34. Laflamme, M.A., Myerson, D., Saffitz, J.E., and Murry, C.E. 2002. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ. Res. 90:634-640.
35. Strauer, B.E., et al. 2002. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 106:1913-1918.
36. Perin, E.C., et al. 2003. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 107:2294-2302.
37. Assmus, B., et al. 2002. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AM1). Circulation. 106:3009-3017.
38. Lee, M.S., and Makkar, R.R. 2004. Stem-cell transplantation in myocardial infarction: a status report. Ann. Intern. Med. 140:729-737.
39. Noguchi, S., Wakabayashi, E., Imamura, M., Yoshida, M., and Ozawa, E. 1999. Developmental expression of sarcoglycan gene products in cultured myocytes. Biochem. Biophys. Res. Commun. 262:88-93.
40. Sampaolesi, M., et al. 2003. Cell therapy of alpha-sarcoglycan null dystrophic mice through intraarterial delivery of mesoangioblasts. Science. 301:487-492.
41. Gussoni, E., et al. 2002. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J. Clin. Invest. 110:807-814. doi:10.1172/ JCI200216098.
42. Wagers, A.J., Sherwood, R.I., Christensen, J.L., and Weissman, I.L. 2002. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 297:2256-2259.
43. Castro, R.F., et al. 2002. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science. 297:1299.
44. Ferrari, G., Stornaiuolo, A., and Mavilio, F. 2001. Failure to correct murine muscular dystrophy. Nature. 411:1014-1015.
45. Ono, K., et al. 2003. Preservation of hematopoietic properties in transplanted bone marrow cells in the brain. J. Neurosci. Res. 72:503-507.
46. Alvarez-Dolado, M., et al. 2003. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 425:968-973.
47. Oh, H., et al. 2003. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U. S. A. 100:12313-12318.
48. Qu-Petersen, Z., et al. 2002. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol. 157:851-864.
49. Rando, T.A., and Blau, H.M. 1994. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125:1275-1287.
50. McNally, E.M., et al. 1996. Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy. Hum. Mol. Genet. 5:1841-1847.
51. Bonnemann, C.G., et al. 1996. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum. Mol. Genet. 5:1953-1961.
52. Lidov, H.G., Byers, T.J., Watkins, S.C., and Kunkel, L.M. 1990. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature. 348:725-728.
53. Nishioka, Y. 1988. Application of Y chromosomal repetitive sequences to sexing mouse embryos. Teratology. 38:181-185.
54. Gussoni, E., et al. 1996. A method to codetect introduced genes and their products in gene therapy protocols. Nat. Biotechnol. 14:1012-1016.